Breast Lymphatic Mapping and Sentinel Lymph Node Biopsy: State of the Art: 2015.

[1]  D. Reintgen,et al.  Extracapsular Extension in the Sentinel Lymph Node: Guidelines for Therapy. , 2016, Clinical breast cancer.

[2]  K. Hunt,et al.  Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0–T4, N1–N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance) , 2016, Annals of surgery.

[3]  S. Steele,et al.  Prognostic Effect of Ultra-Staging Node-Negative Colon Cancer Without Adjuvant Chemotherapy: A Prospective National Cancer Institute-Sponsored Clinical Trial. , 2015, Journal of the American College of Surgeons.

[4]  J. Geraghty,et al.  The Value of Isosulfan Blue Dye in Addition to Isotope Scanning in the Identification of the Sentinel Lymph Node in Breast Cancer Patients With a Positive Lymphoscintigraphy: A Randomized Controlled Trial (ISRCTN98849733). , 2015, Annals of surgery.

[5]  C. Hollenbeak,et al.  Deviation from the Standard of Care for Early Breast Cancer in the Elderly: What are the Consequences? , 2015, Annals of Surgical Oncology.

[6]  B. Taback,et al.  Single Institution Experience with Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for the Primary Prevention of Lymphedema , 2015, Annals of Surgical Oncology.

[7]  Dirk Schadendorf,et al.  Intraoperative Fluorescence Imaging for Sentinel Lymph Node Detection: Prospective Clinical Trial to Compare the Usefulness of Indocyanine Green vs Technetium Tc 99m for Identification of Sentinel Lymph Nodes. , 2015, JAMA surgery.

[8]  S. Ohno,et al.  Clinical Significance of Extracapsular Invasion at Sentinel Lymph Nodes in Breast Cancer Patients with Sentinel Lymph Node Involvement , 2015, Annals of Surgical Oncology.

[9]  A. Papadia,et al.  A Comparison of Radiocolloid and Indocyanine Green Fluorescence Imaging, Sentinel Lymph Node Mapping in Patients with Cervical Cancer Undergoing Laparoscopic Surgery , 2015, Annals of Surgical Oncology.

[10]  H. Kuerer,et al.  Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ? , 2015, Annals of Surgical Oncology.

[11]  A. Giuliano,et al.  Evaluation of the stage IB designation of the American Joint Committee on Cancer staging system in breast cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  E. Rutgers,et al.  Prognostic Significance of Tumor-Positive Internal Mammary Sentinel Lymph Nodes in Breast Cancer: A Multicenter Cohort Study , 2015, Annals of Surgical Oncology.

[13]  G. MacGrogan,et al.  The Role of Sentinel Lymph Node Biopsy and Factors Associated with Invasion in Extensive DCIS of the Breast Treated by Mastectomy: The Cinnamome Prospective Multicenter Study , 2015, Annals of Surgical Oncology.

[14]  K. Pitman,et al.  [99mTc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial , 2015, Annals of Surgical Oncology.

[15]  K. Hunt,et al.  Axillary Ultrasound After Neoadjuvant Chemotherapy and Its Impact on Sentinel Lymph Node Surgery: Results From the American College of Surgeons Oncology Group Z1071 Trial (Alliance). , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  M. Ozawa,et al.  Initial Results with Preoperative Tattooing of Biopsied Axillary Lymph Nodes and Correlation to Sentinel Lymph Nodes in Breast Cancer Patients , 2015, Annals of Surgical Oncology.

[17]  M. Brackstone,et al.  Sentinel node biopsy after neoadjuvant chemotherapy in biopsy-proven node-positive breast cancer: the SN FNAC study. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  N. Kroman,et al.  Sentinel Lymph Node Dissection in Locally Recurrent Breast Cancer , 2015, Annals of Surgical Oncology.

[19]  D. Euhus.  Are Axillary Lymph Nodes Still Relevant in Breast Cancer ? , 2014, Annals of Surgical Oncology.

[20]  H. Kuerer,et al.  Racial disparities in adoption of axillary sentinel lymph node biopsy and lymphedema risk in women with breast cancer. , 2014, JAMA surgery.

[21]  T. Hieken.  The Promise of Axillary Imaging in Individualized Surgical Management of Breast Cancer Patients: Another Step Forward , 2014, Annals of Surgical Oncology.

[22]  B. Fornage,et al.  Predicting the Extent of Nodal Disease in Early-Stage Breast Cancer , 2014, Annals of Surgical Oncology.

[23]  S. Mclaughlin,et al.  Sentinel lymph node surgery after neoadjuvant chemotherapy in patients with node-positive breast cancer: the ACOSOG Z1071 (Alliance) clinical trial. , 2013, JAMA.

[24]  T. Fehm,et al.  Sentinel-lymph-node biopsy in patients with breast cancer before and after neoadjuvant chemotherapy (SENTINA): a prospective, multicentre cohort study. , 2013, The Lancet. Oncology.

[25]  B. Newman,et al.  Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. , 2013, The Lancet. Oncology.

[26]  Linda K. Han,et al.  Comparative Evaluation of [99mTc]Tilmanocept for Sentinel Lymph Node Mapping in Breast Cancer Patients: Results of Two Phase 3 Trials , 2013, Annals of Surgical Oncology.

[27]  D. Reintgen,et al.  Evidence for a Better Nodal Staging System for Melanoma: The Clinical Relevance of Metastatic Disease Confined to the Sentinel Lymph Nodes , 2013, Annals of Surgical Oncology.

[28]  G. Nieuwenhuijzen,et al.  Repeat sentinel node biopsy in patients with locally recurrent breast cancer: a systematic review and meta-analysis of the literature , 2013, Breast Cancer Research and Treatment.

[29]  R. Rouzier,et al.  Anaphylactic response to blue dye during sentinel lymph node biopsy. , 2011, Surgical oncology.

[30]  A. Giuliano,et al.  Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. , 2011, JAMA.

[31]  Donald L. Weaver,et al.  Effect of occult metastases on survival in node-negative breast cancer. , 2011, The New England journal of medicine.

[32]  A. Giuliano,et al.  ACOSOG Z0010: A multicenter prognostic study of sentinel node (SN) and bone marrow (BM) micrometastases in women with clinical T1/T2 N0 M0 breast cancer. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[33]  P. Bult,et al.  Breast cancer prognosis and occult lymph node metastases, isolated tumor cells, and micrometastases. , 2010, Journal of the National Cancer Institute.

[34]  B. Séradour.  [Breast cancer screening in France: an overview in 2009]. , 2010, La Revue du praticien.

[35]  P. V. van Diest,et al.  Micrometastases or isolated tumor cells and the outcome of breast cancer. , 2009, The New England journal of medicine.

[36]  Ya-Chen Tina Shih,et al.  Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[37]  S. Ferrero,et al.  Lymphedema Microsurgical Preventive Healing Approach: A New Technique for Primary Prevention of Arm Lymphedema After Mastectomy , 2009, Annals of Surgical Oncology.

[38]  V. Klimberg.  A new concept toward the prevention of lymphedema: Axillary reverse mapping , 2008, Journal of surgical oncology.

[39]  R. Porcher,et al.  Long-Term Management of Breast Cancer-Related Lymphedema after Intensive Decongestive Physiotherapy , 2007, Breast Cancer Research and Treatment.

[40]  S. Iacobelli,et al.  Axillary Lymph Node Nanometastases Are Prognostic Factors for Disease-Free Survival and Metastatic Relapse in Breast Cancer Patients , 2006, Clinical Cancer Research.

[41]  U. Chetty,et al.  Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. , 2006, Journal of the National Cancer Institute.

[42]  C. Geyer,et al.  Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in five National Surgical Adjuvant Breast and Bowel Project node-positive adjuvant breast cancer trials. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  Mark C Kelley,et al.  Lymphatic mapping and sentinel lymphadenectomy for breast cancer. , 2004, American journal of surgery.

[44]  G. Bisi,et al.  Sentinel lymph node detection in patients with early-stage breast cancer: comparison of periareolar and subdermal/peritumoral injection techniques. , 2004, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[45]  G. Lyman,et al.  Lymphatic Mapping and Sentinel Lymph Node Biopsy , 1999, The breast journal.

[46]  H. Cody,et al.  Lessons learned from 500 cases of lymphatic mapping for breast cancer. , 1999, Annals of surgery.

[47]  R. Foster,et al.  The sentinel node in breast cancer--a multicenter validation study. , 1998, The New England journal of medicine.

[48]  T. Yeatman,et al.  Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. , 1996, JAMA.

[49]  M. Ross,et al.  The Orderly Progression of Melanoma Nodal Metastases , 1994, Annals of surgery.

[50]  D. Weaver,et al.  Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. , 1993, Surgical oncology.

[51]  D L Morton,et al.  Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.

[52]  R. Clark,et al.  The expanding role of lymphoscintigraphy in the management of cutaneous melanoma. First Place Winner: Conrad Jobst award. , 1989, The American surgeon.

[53]  C. Redmond,et al.  Comparison of radical mastectomy with alternative treatments for primary breast cancer , 1978 .

[54]  R. Cabanas,et al.  An approach for the treatment of penile carcinoma , 1977, Cancer.

[55]  J. Devitt.  The influence of conservative and radical surgery on the survival of patients with breast cancer. , 1962, Canadian Medical Association journal.

[56]  W. Halsted,et al.  I. The Results of Operations for the Cure of Cancer of the Breast Performed at the Johns Hopkins Hospital from June, 1889, to January, 1894. , 1894, Annals of surgery.

[57]  E. Port,et al.  Second Axillary Sentinel Lymph Node Biopsy for Breast Tumor Recurrence: Experience of the European Institute of Oncology , 2015 .

[58]  M. Kocherginsky,et al.  The Utility of Sentinel Lymph Node Biopsy in Patients with Ductal Carcinoma In Situ Suspicious for Microinvasion on Core Biopsy , 2014, Annals of Surgical Oncology.

[59]  P. Ravani,et al.  Predictors of Treatment with Mastectomy, Use of Sentinel Lymph Node Biopsy and Upstaging to Invasive Cancer in Patients Diagnosed with Breast Ductal Carcinoma In situ (DCIS) on Core Biopsy , 2013, Annals of Surgical Oncology.

[60]  E. Gershenwald.  Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy , 2007, Annals of Surgical Oncology.

[61]  Pj Ell,et al.  The Sentinel Lymph Node in breast cancer. , 2004 .

[62]  Jong-Hyeon Jeong,et al.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. , 2002, The New England journal of medicine.

[63]  H. Cody,et al.  Intradermal Isotope Injection: A Highly Accurate Method of Lymphatic Mapping in Breast Carcinoma , 2001, Annals of Surgical Oncology.

[64]  M. Mazumdar,et al.  Complementarity of Blue Dye and Isotope in Sentinel Node Localization for Breast Cancer: Univariate and Multivariate Analysis of 966 Procedures , 2001, Annals of Surgical Oncology.

[65]  M. Ross,et al.  Improved Staging of Node-Negative Patients With Intermediate to Thick Melanomas (>1 mm) With the Use of Lymphatic Mapping and Sentinel Lymph Node Biopsy , 2001, Annals of Surgical Oncology.

[66]  M. Yalom.  A History of the Breast , 1997 .

[67]  Gary H Lyman,et al.  Lymphatic mapping and sentinel lymph node biopsy in early‐stage breast carcinoma , 2006, Cancer.